Juan Carlos Jimenez

All opinions are my own.

[AccurKardia @AccurKardia]

AccurKardia and Wellysis have signed a multi-year agreement: our FDA-cleared AccurECG 2.0 will provide the analytics for Wellysis' turnkey cardiac monitoring offering in the U.S. From first integration in April 2025 to multi-year partner.
https://t.co/HHtad5x5oP

[AccurKardia @AccurKardia]

Milestone: AccurKardia's AK-AVS™ aortic stenosis screening software has been accepted into the FDA's TAP program.

[AccurKardia @AccurKardia]

New milestone: AccurKardia granted US Patent No. 12,620,488 for AI-driven ECG detection of cardiac amyloidosis.

An estimated 13-15% of heart failure patients may have it undiagnosed. Earlier detection changes treatment and survival.
https://t.co/cTqGKvZEB7
#AIinCardiology #ECG

[AccurKardia @AccurKardia]

Looking back at our Second Annual Executive Symposium on AI in Cardiovascular Care, hosted in San Juan. Grateful to Dr. Jason Lazar for the keynote and to every clinician and researcher who joined the conversation. The work continues. #AIinCardiology #SaMD

[AccurKardia @AccurKardia]

AK+ Guard™ named "Best New ECG Tech Solution" at the 2026 @MedTech_Awards 🏆 Our AI transforms wearable ECGs into non-invasive biomarkers for hyperkalemia detection.

PR: https://t.co/52k3eERRQ6

*Research use only. Not FDA cleared.

#MedTechBreakthrough #Cardiology

[AccurKardia @AccurKardia]

That’s a wrap on #HRS 2026! 🚀 Our best showing yet for AccurKardia. Huge thanks to our amazing partners Specialized Medical & Wellysis, and to our stellar team on the ground. Check out our Chicago highlights! 👇

Next up: HRX26 in Atlanta & #HRS27 in SF. 🌉 #HealthTech

[AccurKardia @AccurKardia]

#HRS2026 is officially here! ⏳🏙️

We’re in Chicago to showcase the next evolution of automated ECG interpretation. Visit the AccurKardia team and our partners at Specialized Medical at Booth 432 to see our platform in action! 👇

#DigitalHealth #ECG #HealthTech #Cardiology

[AccurKardia @AccurKardia]

We've partnered with Specialized Medical! 🚀

Our FDA-cleared AccurECG™ 2.0 platform is now the analytics engine powering their state-of-the-art cardiac monitoring operations.

Read the full press release: https://t.co/AkI7IsWglb

#ECG #MedTech #DigitalHealth

[AccurKardia @AccurKardia]

Can standard ECGs flag aortic stenosis years earlier and predict higher mortality post-TAVR? Yes. 🫀

@CardioCareToday highlighted groundbreaking research by Dr. @MattSegar (@Texas_Heart). At AccurKardia, our investigational AK-AVS pipeline is turning the standard ECG into a powerful, predictive biomarker for structural heart disease.

Check the interview: https://t.co/c8jir8Iwsv

#AorticStenosis #TAVR #HealthTech #Cardiology #MedTech #AI #BetterOutcomes

[AccurKardia @AccurKardia]

March is #NationalKidneyMonth. To protect the kidneys, we must also look at the heart.

We are tackling Cardiovascular-Kidney-Metabolic (CKM) syndrome by transforming the standard ECG into a more powerful diagnostic tool and broad biomarker.

Read the AHA advisory on CKM: https://t.co/R8dw7CDcBb

[AccurKardia @AccurKardia]

Today is #PulseDay! ❤️ 1 in 3 people are at risk of a serious #arrhythmia in their lifetime.

Taking your pulse is a simple way to protect your heart. Watch this video to learn 3 easy steps to check your rhythm ⬇️

Learn more: https://t.co/XzMbXUoBXf

@escardio @worldheartfed #feelthepulse

[Juan Carlos Jimenez @Juancjbs]

Had a great conversation with Joseph Hashim on #RoundsPodcast. Thanks, Joseph, for the thoughtful questions and a fun deep dive into cardiology deserts, access, and why workflow-friendly ECG software matters.

[AccurKardia @AccurKardia]

Proud to share our CEO, @Juancjbs joined Joseph Hashim on #RoundsPodcast to talk about cardiology deserts and how software can help bridge access.

Episode: “Half of America has no cardiologist. Software bridges access.”
Trailer attached 🎧

Listen: https://t.co/LPr7kwsHkV

#ECG #Cardiology #DigitalHealth #MedTech #AI #BetterOutcomes

[Cardiac Interventions Today @cardiacinterv]

AccurKardia’s AK-AVS AI-Enabled ECG Model Detects Aortic Stenosis Years Before TAVR | @AccurKardia https://t.co/LOu4OzZleU

[AccurKardia @AccurKardia]

New peer-reviewed evidence for AI-ECG in aortic stenosis. Big thanks to Dr. @MattSegar and the Texas Heart Institute team for leading this work.

https://t.co/9X1w5x1epf

AK-AVS is investigational and not FDA-cleared.

[AccurKardia @AccurKardia]

The future of ECG Interpretation is here. 🫀

We are proud to announce FDA 510(k) clearance & launch of AccurECG™ 2.0! (K252361)

✅ Enterprise-grade ✅ Device-agnostic & Vendor Neutral ✅ Results in minutes, not days

#MedTech #Innovation #DigitalHealth #BetterOutcomes #ECG

[AccurKardia @AccurKardia]

Happy New Year '26 from all of us at AccurKardia🎉

Thank you to our customers, partners, and team for a strong 2025 and for supporting our mission to make ECG led diagnostics and biomarkers more scalable and accessible to improve patient outcomes.
#HappyNewYear #ECG #DigitalHealth #MedTech

[AccurKardia @AccurKardia]

Merry Christmas from AccurKardia 🎄❤️
Grateful for everyone helping us expand access to scalable ECG interpretation and ECG biomarkers.

[AccurKardia @AccurKardia]

We are at #AHA25. Nov 8, 1:11 pm CT: AK+ Guard hyperkalemia study with Dr. Nav Razvi. Nov 9, 4:00 pm CT: Health Innovation Pavilion fireside chat with Moin Hussaini and Dr. Tariq Qureshi. Details: https://t.co/0BxWyZby4H. Meet: [email protected]

[AccurKardia @AccurKardia]

Embargo lifted. This weekend at @American_Heart Association Scientific Sessions our team will present “Single Lead ECG AI Model Accurately Predicts Moderate to Severe Hyperkalemia in Multi Hospital External Validation,” using AK+ Guard with Lead I ECG. Session info: https://t.co/9dcgu7oknA

[AccurKardia @AccurKardia]

🎥 Meet AK+ Guard. Lead I ECG from FDA cleared wearables enables hyperkalemia notifications between lab tests, so care teams act sooner. Proud @DigiHlthHubFdn 2025 Digital Health Awards quarterfinalist, Best in Class, AI in Patient Care. #DigitalHealth #AI #ECG #CKD